AzTrials
AzTrials

Obsessive-Compulsive Disorder in AdolescenceNCT05547334

IBA Treatment in Adolescents With OCD

A study testing Inference Based Approach (IBA) in people with Obsessive-Compulsive Disorder in Adolescence, run by Karakter Kinder- en Jeugdpsychiatrie.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both. OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents. Read more about this study

Who is it for?
Ages 12 to 18 years
What is being tested?
Inference Based Approach (IBA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
No sites listed yet
Study dates
1 Nov 2022to 1 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • Primary DSM-5 diagnosis of OCD.
  • A total score of 16 or higher on the CY-BOCS.
  • Age between 12 and 17;11.
  • A completed evidence-based treatment for OCD.
  • Medication must be stable for at least one month.

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • No sufficient knowledge of the Dutch language
  • Autism spectrum disorder (ASD)**
  • Mental retardation (TIQ<80)**
  • Acute suicidality (defined as having suicidal thoughts and plans and/or preparations to ending their life)
  • In case of ASD and/or mental retardation, the IBA protocol maybe too challenging. It is expected that the included cognitive elements, specifically when abstract reasoning is asked, will ask too much of these subjects.

Trial locations and contacts

No sites are listed yet.

L.A.A.C. Webers, Msc contact

06-31915818

l.webers@karakter.com

About this study

Official title: Effect of Inference Based Approach in Adolescents With OCD

Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both. OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents. The first choice treatment for adolescents with OCD is Cognitive Behavioral Therapy (CBT), consisting of exposure with response prevention (ERP) and cognitive interventions. Considering the substantial group of non-responders to CBT, it is necessary to have more options for effective treatment of OCD. Inference Based Approach (IBA) is already an effective treatment for adults with OCD and is more effective on adults with OCD and poor cognitive insight. It is hypothesized that IBA could be an effective alternative for CBT in treating adolescents with OCD. This study will be a first step in examining the efficacy of IBA as treatment for adolescents with OCD.

The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD using a non-concurrent multiple baseline design with 8 participants who receive IBA for 20 sessions performed in one psychiatric centre in the Netherlands.

Read the detailed description

Background of the study:

Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions, compulsions or both (APA, 2014). OCD is a severe psychiatric disorder, affecting many aspects of the lives of adolescents (Weidle et al., 2014; Storch et al., 2018). The first choice treatment for adolescents with OCD is Cognitive Behavioral Therapy (CBT), consisting of exposure with response prevention (ERP) and cognitive interventions (Öst et al., 2016). Treating adolescents with OCD through CBT leads to significant symptom reduction in almost 70% of completed treatments (Öst et al., 2016). However, after completion of treatment, about 50% of adolescents still meet the criteria for OCD (Öst et al., 2016). Adolescents with OCD who do not sufficiently benefit from CBT treatment have severe symptoms, including poor or no insight (Sharma et al., 2021; Nissen \& Parner, 2018; Storch et al., 2014). Considering the substantial group of non-responders to CBT, it is necessary to have more options for effective treatment of OCD. Inference Based Approach (IBA) is already an effective treatment for adults with OCD (O'Connor et al., 2005; Visser et al., 2015) and is more effective on adults with OCD and poor cognitive insight (Visser et al., 2015). It is hypothesized that IBA could be an effective alternative for CBT in treating adolescents with OCD. This study will be a first step in examining the efficacy of IBA as treatment for adolescents with OCD.

Objective of the study:

The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD.

Study design:

A non-concurrent multiple baseline design with 8 participants who receive IBA for 20 sessions perfomed in one psychiatric centre in the Netherlands.

Study population:

8 adolescents from 12 to 17;11 years old with a Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) diagnosis of OCD and a total score of 16 or higher on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). All adolescents included in this study completed an evidence-based treatment for OCD prior to participation.

Intervention (if applicable):

20 sessions IBA treatment.

Primary study parameters/outcome of the study:

Severity of OCD, measured with the CY-BOCS;

Secondary study parameters/outcome of the study (if applicable):

OCD symptomatology, measured with three-weekly ratings of the adolescents' obsessions, compulsions and the level of insight.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness (if applicable):

No burden or risks are expected due to specific elements of the IBA intervention used in this study. Contrary to CBT, treatment elements of IBA will not include exposure to feared consequences while trying to not indulge in compulsions. On top of that, obsessions will not be questioned or challenged. These characteristics may help participants stay motivated to complete treatment and experience improvement in OCD-symptoms.

Being tested
Inference Based Approach (IBA)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inference Based Approach (IBA)Behavioural

    The Inference Based Approach (IBA) (as described by Visser et al., 2015 and adapted for use in adolescents by L. Webers)is a focused form of psychotherapy consists of twenty 45-minutes sessions, delivered weekly and carried out as specified in a Dutch session-by-session IBA protocol, containing standardized forms for exercises and homework assignments. Each session has a standard format, starting with agenda setting and evaluating homework assignments, followed by determining and executing a new exercise and determining new homework. The IBA model is based on the assumption that adolescents with OCD and poor inside misjudge the actual state of affairs. It is assumed that certain reasoning processes lead to these erroneous conclusions and distract the childs attention from observable reality.

Study groups in NCT05547334
Study groupRoleWhat they receive
A non-concurrent multiple baseline designOtherA non-concurrent multiple baseline design
Receives: Behavioral: Inference Based Approach (IBA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in severity of OCD

    measured with the CY-BOCS at T0 = Study intake (baseline phase);T1 = Start treatment phase; i.e. start IBA treatment; T2 = Post-treatment assessment (after IBA treatment); T3 = Follow-up 3 months post-treatment

    Measured: through study completion, an average of 9 months

Secondary outcomes (3)
  1. Change in OCD symptomatology

    measured with three-weekly ratings of the adolescents' obsessions, compulsions and the level of insight.

    Measured: three-weekly questions during the intervention

  2. Treatment history (psychotherapy and medication)

    Treatment history (psychotherapy and medication)

    Measured: T0 = Study intake (baseline phase)

  3. Change in current medication use

    Current medication use at T0 = Study intake (baseline phase) T1 = Start treatment phase; i.e. start IBA treatment T2 = Post-treatment assessment (after IBA treatment) T3 = Follow-up 3 months post-treatment

    Measured: through study completion, an average of 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2022
  2. Study start1 Nov 2022 (estimated)
  3. Primary completion1 Nov 2023 (estimated)
  4. Study completion1 Nov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
A non-concurrent multiple baseline design
Masking
None (open label)
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05547334
Sponsor's protocol ID
217-22
Other IDs
NL81157.091.22
Status last verified
Sep 2022
First submitted
14 Sep 2022
Last updated
22 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Inference Based Approach (IBA) in people with Obsessive-Compulsive Disorder in Adolescence, run by Karakter Kinder- en Jeugdpsychiatrie.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact L.A.A.C. Webers, Msc (06-31915818, l.webers@karakter.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in severity of OCD (time frame: through study completion, an average of 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in